Skip to main content
Cutia Therapeutics logo

Cutia Therapeutics — Investor Relations & Filings

Ticker · 2487 HKEX Manufacturing
Open in API
Filings indexed 176 across all filing types
Latest filing 2025-08-28 Governance Information
Country HK Hong Kong
Listing HKEX 2487

About Cutia Therapeutics

http://www.cutiatx.com

Cutia Therapeutics is an R&D-driven biopharmaceutical platform established in 2019, specializing in the research, development, manufacture, and commercialization of dermatological treatments. The company is dedicated to providing a comprehensive suite of innovative, safe, and effective solutions for patients and consumers. Its core therapeutic focus areas include the management of localized adipose accumulation and various scalp diseases. As a dermatology-focused entity, Cutia maintains a dedicated pipeline emphasizing novel candidates, including those targeting the Immune System domain.

Recent filings

Filing Released Lang Actions
TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE OF CUTIA THERAPEUTICS
Governance Information Classification · 1% confidence The document is the officially adopted Terms of Reference for the Nomination Committee of the company’s Board. It outlines committee composition, duties, authority, and governance procedures. This is a corporate governance policy document detailing internal rules and board structure, matching the “Governance Information” category.
2025-08-28 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 1% confidence The document is a standalone announcement listing the company’s directors, their roles, and committee memberships. It does not include full financial data or executive compensation schedules, nor does it announce an AGM presentation or voting results. It clearly pertains to board composition and governance structure, fitting the Board/Management Information category.
2025-08-28 English
(1) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR&#x3b; AND (2) CHANGE OF MEMBERS OF NOMINATION COMMITTEE AND AUDIT COMMITTEE
Board/Management Information Classification · 1% confidence The document is an official announcement by the company’s board regarding the resignation of an existing independent non-executive director and the appointment of a new one, as well as the consequent changes in membership of the Audit Committee and Nomination Committee. This clearly falls under announcements of changes in the company’s board of directors or senior management.
2025-08-28 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025' and contains detailed business reviews, product pipeline updates, and management discussion regarding the company's performance for that specific period. While it is an announcement, it provides substantive financial and operational data for the interim period, fitting the definition of an Interim/Quarterly Report (IR). H2 2025
2025-08-28 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is a brief regulatory announcement notifying investors of the date of the company’s Board meeting to consider, approve and publish its interim results. It does not contain the report itself but merely announces the timing of its publication, matching the definition of a Report Publication Announcement (RPA).
2025-08-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Share Issue/Capital Change Classification · 1% confidence The document is a Hong Kong Exchange (HKEX) monthly return under Chapter 19B of the Listing Rules detailing movements in authorized share capital, issued shares, treasury shares, share option schemes and other share-related arrangements. It is not an earnings release or AGM material, nor a transcript, proxy statement, or dividend notice. It is a regulatory report focused exclusively on share capital movements and issuance mechanics. This corresponds to the “Share Issue/Capital Change” category (SHA).
2025-08-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.